Briviact Shortage Update for 2026

If you take Briviact (Brivaracetam) for seizures, you may have heard rumors about a shortage — or experienced difficulty finding it at your pharmacy firsthand. In this article, we'll give you the latest information about Briviact availability in 2026, explain why it can be hard to find, and share practical steps you can take to keep your seizure treatment on track.

Is Briviact Still in Shortage?

As of early 2026, Briviact is not listed on the FDA or ASHP official drug shortage lists. This means there is no confirmed nationwide manufacturing or supply chain shortage affecting Briviact production.

However, that doesn't mean every pharmacy has it in stock. Many patients continue to report difficulty finding Briviact at their local chain pharmacies. The issue is more about pharmacy stocking patterns than an actual shortage. Because Briviact is a specialty medication used by a relatively small patient population, many pharmacies simply don't keep it on their shelves.

Why Is Briviact Hard to Find?

Even without a formal shortage, several factors make Briviact harder to find than more common medications:

• Low demand at individual pharmacies: Briviact is prescribed primarily by neurologists and epileptologists for partial-onset seizures. Most local pharmacies may only have one or two patients who need it, which doesn't justify stocking it regularly.
• High cost: With a list price of approximately $1,511 per month in 2026, Briviact is an expensive medication. Some pharmacies are hesitant to stock high-cost drugs that may sit on shelves.
• New generic competition: Generic Brivaracetam has been approved by the FDA, but distribution is still ramping up. During this transition period, both brand and generic may be inconsistently available.
• Insurance barriers: Prior authorization requirements and step therapy protocols can delay fills, creating the appearance of unavailability.

For a deeper dive into these issues, read our article on why Briviact is so hard to find.

How Much Does Briviact Cost in 2026?

The cost of Briviact varies depending on your insurance, pharmacy, and whether you use the brand or generic:

• Brand-name Briviact: Approximately $1,450-$1,550 per month (cash price for a 30-day supply of tablets)
• Generic Brivaracetam: Pricing varies, but generics are expected to cost significantly less — potentially $200-$600 per month as availability increases
• With the UCB Savings Card: Eligible commercially insured patients may pay as little as $10 per month
• With insurance: Copays vary widely by plan, typically $30-$150 per month for commercially insured patients with approved prior authorization

For more cost-saving strategies, see our guide on how to save money on Briviact.

New Options in 2026

The epilepsy treatment landscape continues to evolve. Here are some developments that may affect Briviact patients in 2026:

• Generic Brivaracetam: Now FDA-approved from multiple manufacturers including Aurobindo, Lupin, MSN, Sunshine, and Zydus. As these generics become more widely distributed, availability should improve and prices should come down.
• Alternative AEDs: Newer medications like Cenobamate (Xcopri) have gained traction and may offer additional options for patients with partial-onset seizures. Learn more in our alternatives to Briviact article.

How to Find Briviact in Stock

Here's what to do right now if you need Briviact:

1. Check Medfinder: Use Medfinder to search for pharmacies near you that currently have Briviact in stock.
2. Call independent pharmacies: They're often more willing to order specialty medications and can usually get them within 1-2 days.
3. Ask about the generic: Your pharmacist may be able to source generic Brivaracetam even if the brand isn't available.
4. Try mail-order: Contact your insurance company about mail-order pharmacy options for home delivery.
5. Contact UCBCares: Call 833-948-2394 for help finding a pharmacy or accessing financial assistance.

For detailed tips, read our full guide on how to find Briviact in stock near you.

Final Thoughts

While Briviact is not in a formal shortage in 2026, real-world availability remains a challenge for many patients. The emergence of generic Brivaracetam is a positive development, but it will take time for supply chains to fully mature. In the meantime, be proactive: use tools like Medfinder, explore independent pharmacies, and work closely with your healthcare team to ensure uninterrupted seizure control.

Want to know more about Briviact itself? Read our comprehensive guide on what Briviact is, its uses, and dosage.